News - Page 17 - Psychedelic Alpha

Read more about the article Bay Staters for Natural Medicine Co-Founder, James Davis, on Grassroots Psychedelic Policy Reform, a Community-based Facilitator Network, and the Corporatisation of Psychedelics

Bay Staters for Natural Medicine Co-Founder, James Davis, on Grassroots Psychedelic Policy Reform, a Community-based Facilitator Network, and the Corporatisation of Psychedelics

Post published:March 8, 2024
Post category:Interviews

Read more about the article FDA Hands MindMed’s LSD Candidate Breakthrough Therapy Designation in Generalised Anxiety Disorder; Company Provides 12-Week Data and Fleshes Out Phase 3 Program Plans

FDA Hands MindMed’s LSD Candidate Breakthrough Therapy Designation in Generalised Anxiety Disorder; Company Provides 12-Week Data and Fleshes Out Phase 3 Program Plans

Post published:March 7, 2024
Post category:Analysis News Pα+

Read more about the article Pα+ Psychedelic Bulletin #158: Fluence Brings Psychedelic Therapy Training to Ukraine; MindBio’s Microdosing Readout; Biomind’s 5-MeO-DMT Study; and more…

Pα+ Psychedelic Bulletin #158: Fluence Brings Psychedelic Therapy Training to Ukraine; MindBio’s Microdosing Readout; Biomind’s 5-MeO-DMT Study; and more…

Post published:March 6, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Prominent At-Home Ketamine Co. Founder, Juan Pablo Cappello, Sounds Alarm, Withdraws Support for the Practice

Prominent At-Home Ketamine Co. Founder, Juan Pablo Cappello, Sounds Alarm, Withdraws Support for the Practice

Post published:March 4, 2024
Post category:Analysis News Pα+

Read more about the article The Psychedelic News Feed: Feb 5, 2024 – Mar 3, 2024

The Psychedelic News Feed: Feb 5, 2024 – Mar 3, 2024

Post published:March 4, 2024
Post category:Psychedelic News Feed Archive

Read more about the article Pα+ Psychedelic Bulletin #157: Psilocybin for Generalised Anxiety Disorder; Uptick in Psilocybin-Related Poison Centre Calls

Pα+ Psychedelic Bulletin #157: Psilocybin for Generalised Anxiety Disorder; Uptick in Psilocybin-Related Poison Centre Calls

Post published:March 1, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Colorado’s Draft Natural Medicine Rules: Full Breakdown & Commentary

Colorado’s Draft Natural Medicine Rules: Full Breakdown & Commentary

Post published:February 27, 2024
Post category:Colorado Natural Medicine Advisory Bulletin

Read more about the article Colorado’s Draft Natural Medicine Rules: A High-Level Overview

Colorado’s Draft Natural Medicine Rules: A High-Level Overview

Post published:February 27, 2024
Post category:Colorado Natural Medicine Advisory Bulletin

Read more about the article Ibogaine Advocates Seek Ohio Opioid Settlement Funds Following Failure in Kentucky

Ibogaine Advocates Seek Ohio Opioid Settlement Funds Following Failure in Kentucky

Post published:February 23, 2024
Post category:Analysis News

Read more about the article Pα+ Psychedelic Patent Analysis: A Mebufotenin Melee (Dec ’23 & Jan ’24)

Pα+ Psychedelic Patent Analysis: A Mebufotenin Melee (Dec ’23 & Jan ’24)

Post published:February 22, 2024
Post category:Psychedelic Patent Analysis Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.